Meeting report: Vienna 2008 Workshop of the German–Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes

Peter Valent (1) , Wolf-Karsten Hofmann (2) , Guntram Büsche (3) , Karl Sotlar (4) , Hans-Peter Horny (5) , Detlef Haase (6) , Torsten Haferlach (7) , Wolfgang Kern (7) , Peter Bettelheim (8) , Christian Baumgartner (1) , Wolfgang R. Sperr (1) , Thomas Nösslinger (9) , Friedrich Wimazal (1) , Aristoteles A. Giagounidis (10) , Michael Lübbert (11) , Otto Krieger (12) , Hans-Jochem Kolb (13) , Reinhard Stauder (14) , Michael Pfeilstöcker (9) , Norbert Gattermann (15) , Christa Fonatsch (16) , Carlo Aul (10) , Ulrich Germing (15)

1 Department of Internal Medicine I, Division of Hematology & Hemostaseology
2 Department of Hematology, Oncology and Transfusion Medicine
3 Institute of Pathology
4 Institute of Pathology
5 Klinikum Ansbach, Institute of Pathology
6 Department of Hematology and Oncology
7 MLL Munich Leukemia Laboratory
8 Institute for Laboratory Medicine
9 Ludwig-Boltzmann Institute for Leukemia Research and Hematology
10 Medizinische Klinik II
11 Division of Hematology/Oncology, Department of Medicine
12 First Department of Internal Medicine
13 Department of Medicine III
14 Division of Hematology and Oncology
15 Department of Haematology, Oncology and Clinical Immunology
16 Department of Medical Genetics

Criteria, scoring systems, and treatment algorithms for myelodysplastic syndromes (MDS) have been updated repeatedly in recent years. This apparently results from increased awareness and early recognition of the disease, an increasing number of new diagnostic and prognostic markers and tools, and new therapeutic options that may change the course and thus prognosis in MDS. To address these challenges and to create useful new diagnostic and prognostic parameters and scores, the German–Austrian Working Group for Studying Prognostic Factors in MDS was established in 2003 and later was extended to centers in Switzerland (D-A-CH group). In addition, the group cooperates with the European LeukemiaNet, the MDS Foundation, and other national and international working groups in order to improve diagnosis and prognostication. The current article represents a meeting report from the latest workshop organized by the group in Vienna in October 2008.

Mots clés: Myelodysplastic syndromes; Criteria; Prognostication; Standardization; MDS registry

Peter Valent, Wolf-Karsten Hofmann, Guntram Büsche, Karl Sotlar, Hans-Peter Horny, et al.. Meeting report: Vienna 2008 Workshop of the German–Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes. Annals of Hematology, 2009, 88 (7), pp.607-611. ⟨10.1007/s00277-008-0673-7⟩. ⟨hal-00535018⟩